ARLG is changing the field of clinical research in antimicrobial resistance. We will talk with the Principal Investigators of the ARLG to discuss their strategy
• Review the history and accomplishments of ARLG
• Discuss the missions of ARLG including training new clinical investigators focused on antibiotic resistance
• Comment of the future of ARLG and clinical research on antibiotic resistance
Joining me to talk about ARLG are the principal investigators of this ambitious effort:
• Dr. Vance Fowler: Professor of Medicine, Florence McAlister Distinguished Professor of Medicine, Professor in Molecular Genetics and Microbiology, Duke University.
• Dr. Henry “Chip” Chambers: Professor of Medicine, Emeritus. University of California, San Francisco
Visit aac.asm.org to read the current issue.
The Center of Diseases Control and Prevention (CDC) has categorized emergent resistance in Neisseria gonorrhoeae as an “urgent” public health problem. We discuss the emerging problem of gonorrhea and implications for public health with experts in the field
Topics discussed: The clinical...
We can probably all agree that any false positive test result is bad, but I think it’s safe to say that some false positives, like a false positive HIV test for example, is much more anxiety provoking than others. And when it comes to HIV, there have been a number of key advances in the field...